ADSL and obesity disorder: As proposed by Szczepocka et al., an increase in AMPs in situations such as obesity is expected, as cathelicidin is linked with inflammatory diseases, and the mechanism connecting obesity with altered antimicrobial peptide expression may be located within the adipose tissue [30].